Skuldtech is an innovative biotechnology company, which provides innovative solutions for diagnosis and therapeutical purposes.

The objective of the company is to construct a biomarker and product portfolio as well as a technological intellectual property pipeline.

Biomarkers validated in clinical trials will either be out-licensed or used in-house for final products.

Due to its expertise in genomics, Skuldtech is currently involved in various fields:

• Discovery of biomarkers,
• Diagnosis tool development,
• Personalized medicine and companion diagnostic development.

Skuldtech is focusing its actions on cancer research and infectious diseases.